Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update

NEXT STORY
N95 Mask Market Size, Share & Trends Analysis Report By Product, By Distribution Channel, By End Use, By Region And Segment Forecasts, 2020 – 2027
PREV STORY
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Exagen Points the Way for Patients with Difficult-to-Diagnose Disease

May is Lupus Awareness Month San Diego, Ca and Albuquerque, NM, May 02, 2018 ...

author_avatar
NASDAQ Market News

Horizon Pharma plc Completes Sale of European Marketing Rights for PROCYSBI® (cysteamine bitartrate) delayed-release capsules and QUINSAIR™ (levofloxacin nebuliser solution) in Europe, Middle East and Africa (EMEA) Regions to Chiesi Farmaceutici S.p.A.

DUBLIN, Ireland, June 23, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) (Horizon), a ...

author_avatar
NASDAQ Market News

Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel

author_avatar
NASDAQ Market News